Class information for:
Level 1: HPMA COPOLYMERS//HPMA COPOLYMER//POLYMER THER EUT

Basic class information
ID Publications Average number
of references		 Avg. shr. active
ref. in WoS
7275 1310 44.7 74%


Bar chart of Publication_year

Last years might be incomplete

Classes in level above (level 2)


ID, lev.
above		 Publications Label for level above
2307 4094 HPMA COPOLYMERS//HPMA COPOLYMER//PEGYLATION

Terms with highest relevance score


Rank Term Type of term Relevance score
(tfidf)		 Class's shr.
of term's tot.
occurrences		 Shr. of publ.
in class containing
term		 Num. of
publ. in
class
1 HPMA COPOLYMERS Author keyword 137 91% 4% 58
2 HPMA COPOLYMER Author keyword 79 75% 4% 57
3 POLYMER THER EUT Address 46 53% 5% 61
4 N 2 HYDROXYPROPYLMETHACRYLAMIDE COPOLYMERS Author keyword 31 92% 1% 12
5 POLYMER THERAPEUTICS Author keyword 28 46% 4% 46
6 HPMA Author keyword 23 53% 2% 31
7 POLYMER DRUG CONJUGATES Author keyword 16 44% 2% 28
8 INNOVAT CANC DIAG THER Y Address 15 88% 1% 7
9 MESOCHLORIN E6 Author keyword 15 88% 1% 7
10 N 2 HYDROXYPROPYLMETHACRYLAMIDE HPMA Author keyword 14 100% 1% 7

Web of Science journal categories

Author Key Words


Rank Web of Science journal category Relevance score
(tfidf)		 Class's shr.
of term's tot.
occurrences		 Shr. of publ.
in class containing
term		 Num. of
publ. in
class		 LCSH search Wikipedia search
1 HPMA COPOLYMERS 137 91% 4% 58 Search HPMA+COPOLYMERS Search HPMA+COPOLYMERS
2 HPMA COPOLYMER 79 75% 4% 57 Search HPMA+COPOLYMER Search HPMA+COPOLYMER
3 N 2 HYDROXYPROPYLMETHACRYLAMIDE COPOLYMERS 31 92% 1% 12 Search N+2+HYDROXYPROPYLMETHACRYLAMIDE+COPOLYMERS Search N+2+HYDROXYPROPYLMETHACRYLAMIDE+COPOLYMERS
4 POLYMER THERAPEUTICS 28 46% 4% 46 Search POLYMER+THERAPEUTICS Search POLYMER+THERAPEUTICS
5 HPMA 23 53% 2% 31 Search HPMA Search HPMA
6 POLYMER DRUG CONJUGATES 16 44% 2% 28 Search POLYMER+DRUG+CONJUGATES Search POLYMER+DRUG+CONJUGATES
7 MESOCHLORIN E6 15 88% 1% 7 Search MESOCHLORIN+E6 Search MESOCHLORIN+E6
8 N 2 HYDROXYPROPYLMETHACRYLAMIDE HPMA 14 100% 1% 7 Search N+2+HYDROXYPROPYLMETHACRYLAMIDE+HPMA Search N+2+HYDROXYPROPYLMETHACRYLAMIDE+HPMA
9 SMANCS 10 73% 1% 8 Search SMANCS Search SMANCS
10 PACLITAXEL POLIGLUMEX 10 57% 1% 12 Search PACLITAXEL+POLIGLUMEX Search PACLITAXEL+POLIGLUMEX

Key Words Plus


Rank Web of Science journal category Relevance score
(tfidf)		 Class's shr.
of term's tot.
occurrences		 Shr. of publ.
in class containing
term		 Num. of
publ. in
class
1 N 2 HYDROXYPROPYL METHACRYLAMIDE COPOLYMERS 96 93% 3% 37
2 ENZYMATICALLY DEGRADABLE BONDS 88 72% 5% 69
3 N 2 HYDROXYPROPYLMETHACRYLAMIDE COPOLYMERS 72 62% 6% 74
4 NATURAL MACROMOLECULES 62 92% 2% 24
5 OLIGOPEPTIDE SEQUENCES 48 91% 2% 20
6 BOUND ADRIAMYCIN 42 94% 1% 15
7 N 2 HYDROXYPROPYLMETHACRYLAMIDE COPOLYMER DOXORUBICIN 40 76% 2% 28
8 HPMA COPOLYMER 36 61% 3% 38
9 PH CONTROLLED ACTIVATION 35 67% 2% 31
10 BOUND DOXORUBICIN 33 75% 2% 24

Journals

Reviews


Title Publ. year Cit. Active references % act. ref.
to same field
The EPR effect for macromolecular drug delivery to solid tumors: Improvement of tumor uptake, lowering of systemic toxicity, and distinct tumor imaging in vivo 2013 189 74 31%
The dawning era of polymer therapeutics 2003 1763 105 29%
Polymer conjugates as anticancer nanomedicines 2006 881 100 45%
HPMA copolymers: Origins, early developments, present, and future 2010 151 153 59%
HPMA copolymer-anticancer drug conjugates: design, activity, and mechanism of action 2000 344 110 72%
Polymeric drugs for efficient tumor-targeted drug delivery based on EPR-effect 2009 422 95 33%
The enhanced permeability and retention (EPR) effect in tumor vasculature: The key role of tumor-selective macromolecular drug targeting 2001 953 44 36%
Polymer-drug conjugates: Origins, progress to date and future directions 2013 65 146 53%
Development of HPMA copolymer-anticancer conjugates: Clinical experience and lessons learnt 2009 101 79 92%
Polymer therapeutics-prospects for 21st century: The end of the beginning 2013 79 39 44%

Address terms


Rank Address term Relevance score
(tfidf)		 Class's shr.
of term's tot.
occurrences		 Shr. of publ.
in class containing
term		 Num. of
publ. in
class
1 POLYMER THER EUT 46 53% 4.7% 61
2 INNOVAT CANC DIAG THER Y 15 88% 0.5% 7
3 PHARMACEUT PHARMACEUT CHEM 11 11% 7.6% 100
4 UTAH PHOTOMED 8 100% 0.4% 5
5 CCCD 8 28% 1.8% 23
6 CLIN COOPERAT UNIT RADIOTHER EUT ONCOL 6 53% 0.6% 8
7 MICROBIOL ONCOL 5 25% 1.5% 19
8 PHARMACEUT PHARMACEUT CHEM CCCD 4 40% 0.6% 8
9 NANO UTAH 4 20% 1.2% 16
10 DRUG DELIVERY SCI 3 57% 0.3% 4

Related classes at same level (level 1)


Rank Relatedness score Related classes
1 0.0000181081 GRP PEPTIDE CHEM//BRANCHED POLYPEPTIDES//HUNGARIAN SCI PEPTIDE CHEM GRP
2 0.0000144676 POLYMERIC MICELLES//POLYMERIC MICELLE//PLURONIC MICELLES
3 0.0000130627 CHAIN COPOLYMERIZATION//INHIBITORS OF AGGREGATION//INVIVO CULTURE
4 0.0000123579 DRUG DELIVERY//GALACTOSYLATED LIPOSOMES//N SUCCINYL CHITOSAN
5 0.0000100961 ANTIBODY DRUG CONJUGATE//ANTIBODY DRUG CONJUGATES//T DM1
6 0.0000097825 PEGYLATION//MONOMETHOXYPOLYETHYLENE GLYCOL//BRANCHED PEG
7 0.0000087174 QUIM FARMACEUT ORGAN//BENZODIOXEPINS//IN VIVO ANTITUMOUR ACTIVITY
8 0.0000084268 CANCER NANOTECHNOLOGY//NANOSCI NANOENGN INITIAT NUSNNI//CHEMOTHERAPEUTIC ENGINEERING
9 0.0000080153 LIPOSOMAL CISPLATIN//LIPOPLATIN//SPI 077
10 0.0000079717 POLYMALIC ACID//POLYMALATASE//UMR C7581